<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Aptos;}
@font-face
	{font-family:"Aptos Display";}
@font-face
	{font-family:"DengXian Light";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:"\@DengXian Light";}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Aptos Display",sans-serif;
	color:#0F4761;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:107%;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Aptos",sans-serif;
	color:#0F4761;
	font-weight:normal;}
a:link, span.MsoHyperlink
	{color:#467886;
	text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Aptos",sans-serif;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Aptos Display",sans-serif;
	color:#0F4761;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"DengXian Light";
	color:#0F4761;}
.MsoChpDefault
	{font-family:"Aptos",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU link="#467886" vlink="#96607D" style='word-wrap:break-word'>

<div class=WordSection1>

<h2>2025ADVANCE Describe the pharmacology of methadone.</h2>

<p class=MsoNormal>&nbsp;</p>

<h3>tl;dr</h3>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Long-acting multi-modal analgesia confers risks</p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Long-acting multi-modal analgesia confers benefits</p>

<p class=MsoNormal>&nbsp;</p>

<h3>Physicochemical:</h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Origin</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>First synthesised in Germany… in 1937…</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Presentation</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Oral (tablet, liquid) from any Fitzroy pharmacy</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>IV methadone HCl 10mg/mL from any proper anaesthetist</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Chemistry</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Synthetic diphenylheptanone</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>MW 346g/mol</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>pKa 8.5, 10% unionised</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Highly lipid soluble (Octanol:Water 115)</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Stereochemistry</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Racemic mixture</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>R-methadone: opioid</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>S-methadone: NMDA antagonist, monoamine reuptake inhibitor,
  &#8593;QTc</p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<h3>Pharmacokinetic</h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Administration</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>PO</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>IV, IM, SC</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Time course</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Onset: within minutes</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Peak: analgesia 10 mins, resp depression ?30mins<br>
  (that’s nowhere near as long as morphine)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Duration: dose-dependent</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:
  -18.0pt;line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span>10mg: few
  hours</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:
  -18.0pt;line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span>20mg: 1 day</p>
  <p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;text-indent:-18.0pt;
  line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span>30mg: 3 days</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Absorption</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Oral bioavailability 75%: low first pass hepatic metabolism</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Variable time to peak effect 1-5 hours</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Distribution</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Highly bound to plasma proteins (&#945;1AG, 90%)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Extensively distributed (VD<sub>ss</sub> 6L/kg)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Moderately quick distribution to tissues (t<sub>1/2&#945;</sub>
  6 mins)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Moderately quick equilibration with CNS (t<sub>1/2ke0</sub> 8
  mins)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Crosses placenta. Pregnancy Class C</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Small amounts in breast milk (N.B. minimal intake in first week
  FML)</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Metabolism</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;text-align:justify;line-height:
  normal'><u>Pathways:</u></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Hepatic Phase 1 N-demethylation</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>2B6, 3A4 &gt; 2C19, 2C9, 2D6</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Major metabolite inactive (EDDP -&gt; EMDP)</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Minor metabolite weakly active (nor-methadol)</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u>Speed:</u></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Longest duration of all opioids</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Cl 6mL/kg/min</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>t<sub>1/2&#946;</sub> 15-60 hours, mean 1 day</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u>Variability:</u></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Significant 2B6 polymorphism (also 2C19, 2D6 but less
  important)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Reduced function alleles common worldwide</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Oceania (60%) &gt; Africa (40%) &gt; Europe (30%) &gt; Asia
  (20%)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Affects S-methadone &gt;&gt; R-methadone</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Repeat dosing -&gt;  &#8593;&#8593;[S-methadone] -&gt;
  &#8593;QTc, &#8593;5HT</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Minimal effect on duration of opioid activity</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Excretion</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Parent -&gt; Urine (10%)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-bottom:0cm;text-indent:
  -18.0pt;line-height:normal'><span style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span>&#8593; if
  &#8595;pH (up to 30%)</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Metabolites -&gt; bile, urine</p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<h3>Pharmacodynamic</h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Receptor
  effects</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Full &#956; opioid agonist</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>NMDA antagonist (contribution unknown, likely less than
  ketamine)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>NAd and 5HT reuptake inhibitor</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>hERG* Cardiac K+ channel inhibitor</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>&nbsp;</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><span
  style='font-size:8.0pt'>*hERG = human ether-a-go-go related gene<br>
  Researchers doing experiments on drosophila melanogaster (fruitfly)<br>
  Some responded unusually to ether anaesthesia<br>
  They started moving their legs as if they were dancing<br>
  Was caused by a mutation in a voltage-gated potassium channel</span></p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Thresholds</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Severe Resp Depression: ~100ng/mL</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Complete Analgesia: ~60ng/mL</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Partial Analgesia: ~30ng/mL</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Uses</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Acute &amp; chronic pain</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Somatic &amp; visceral &amp; neuropathic pain</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Evidence base across many surgical specialties</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Opioid addiction &amp; withdrawal</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Benefits</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>&#8595;Opioid side effects (cf. pure opioids at equi-analgesic
  doses)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>&#8595;Opioid use (up to 3/12 post-op)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>&#8595;Pain scores (up to 3/12 post-op)</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>The above could reduce the risk of long-term use and addiction</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Respiratory
  depression</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Especially with benzodiazapines, gabapentinoids</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Especially if sleep-disordered breathing</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Partial reversal of effect with naloxone</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Highest risk 30-45 mins (cf. intrathecal morphine 6-12 hours)</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Serotonin
  syndrome</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>It’s real and I’ve seen a mild variant from a single dose</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Mostly with high doses and repeat doses</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Mostly if combined with other serotonergic drugs</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Mostly if multiple mechanisms</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Worst: MAOi (14 days offset), tramadol, pethidine</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;line-height:normal'>(MAOis: methylene
  blue, moclobemide, selegiline)</p>
  </td>
 </tr>
 <tr>
  <td width=123 valign=top style='width:91.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Torsades de
  Pointes</p>
  </td>
  <td width=479 valign=top style='width:358.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Inhibits cardiac K<sup>+</sup> channels -&gt; &#8593;QTc <i>and</i>
  &#8593;risk TdP</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Risk factors: Congenital long QT, Class 3 antiarrhythmic,
  &#8595;K<sup>+</sup>, &#8595;Mg<sup>2+</sup></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Mostly (but not always) with repeated high dose (&gt;100mg/day)</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Could be mimicked with a big IV push</p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><br>
<br>
</p>

<h3>PK &amp; PD:</h3>

<p class=MsoNormal><img width=583 height=387 id="Picture 1"
src="2025ADVANCE_methadone_files/image001.jpg"></p>

<h3>User’s Guide:</h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=128 valign=top style='width:95.9pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Dosing</p>
  </td>
  <td width=473 valign=top style='width:354.9pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Day case: 5-10mg (e.g. elective lap chole. Is it worth it?)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Overnight stay: 10-20mg (e.g. joint replacement)</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>ICU major: 20-30mg (e.g. liver resection)</p>
  </td>
 </tr>
 <tr>
  <td width=128 valign=top style='width:95.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Timing</p>
  </td>
  <td width=473 valign=top style='width:354.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Give a bit at a time, e.g. 2-3mg q2-3 mins</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Give most of it early: anaesthetic room vs induction vs pre-incision</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Give a small top up at end of case if needed</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Titrate against pupil size, RR, PaCO2 at steady state</p>
  </td>
 </tr>
 <tr>
  <td width=128 valign=top style='width:95.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Adjuvants</p>
  </td>
  <td width=473 valign=top style='width:354.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u>Pure
  Opioids</u>: <i>Careful</i></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Induction: use short-acting opioid</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Recovery: as usual</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Ward: as usual. Lower dose or PCA if concerned.</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Long acting: no intrathecal morphine. No slow-release opioid.</p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:36.0pt;text-indent:-36.0pt;line-height:normal'><u>Benzodiazepines</u>:
  <i>Careful</i></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Kharasch advises extreme caution</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Avoid if short procedure / day case / sleep-disordered
  breathing</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Small dose (0.5-2mg) ok when lining up for a long &amp; major
  procedure</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Opioids aren’t anxiolytic, come at me</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u>Alph 2 Agonists</u>:
  <i>Careful</i></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Kharasch advises extreme caution</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Clonidine: too sedating, too long-acting</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Dexmed: must use EEG to titrate anaesthetic agent</p>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u>Ketamine</u>:
  <i>Yes</i></p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Significant additional analgesic benefit</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Minimal respiratory depression</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Give as you normally would</p>
  </td>
 </tr>
 <tr>
  <td width=128 valign=top style='width:95.9pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'>Anaesthetic</p>
  </td>
  <td width=473 valign=top style='width:354.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;line-height:normal'><u>Wakeup
  Strategies</u>: (for long procedure + comfortable patient)</p>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Processed EEG for titration</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Sevoflurane -&gt; propofol +/- remifentanil (mid-procedure
  switch)</p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>Sevoflurane -&gt; desflurane (mid-procedure switch, if you’re
  evil)</p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:15.95pt;text-indent:-14.15pt;line-height:normal'><span
  style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span>(Sevoflurane’s 90% decrement time climbs steeply after 2 hours)</p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<h3>Credits</h3>

<p class=MsoNormal>Thanks to Harsh Dubey for teaching me the most out of anyone</p>

<p class=MsoNormal>Thanks to John Webster for his excellent literature review</p>

<p class=MsoNormal>Thanks to Evan Kharasch for resurrecting and advancing this
topic</p>

<p class=MsoNormal>Thanks to Geoffrey Gourlay for his pioneering work</p>

<p class=MsoNormal>Thanks to Sarah Lee for organising this whole thing</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>Feedback welcome at <a
href="mailto:ketaminenightmares@gmail.com">ketaminenightmares@gmail.com</a></p>

<p class=MsoNormal>&nbsp;</p>

</div>

</body>

</html>
